Levi Hargrove

Levi Hargrove, PhD, is a founding partner of Coapt, a company that sells intuitive neural interfaces for assistive devices and phantom limb pain suppression. Founded in 2012 in Chicago, IL, Coapt has released three FDA-Cleared Class II product lines that use AI-based approaches to decode movement intentions from non-invasively acquired biosignals and map the decoded commands to virtual environments, robotic limbs or exoskeletons.

Dr. Hargrove is also the Director of the Regenstein Center for Bionic Medicine at the Shirley Ryan AbilityLab and is an Associate Professor at Northwestern University in the Departments of PM&R and Biomedical Engineering.  He manages a research budget of over $25 million in grant funding from federal, military and philanthropic sources and oversees the world’s largest prosthetics and orthotics academic research group.